T3 DEFENSE INC (DFNS) Fundamental Analysis & Valuation

NASDAQ:DFNS • US67054R2031

1.235 USD
+0.03 (+2.07%)
Last: Mar 13, 2026, 10:05 AM

This DFNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

0

Overall DFNS gets a fundamental rating of 0 out of 10. We evaluated DFNS against 277 industry peers in the Software industry. DFNS has a bad profitability rating. Also its financial health evaluation is rather negative. DFNS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. DFNS Profitability Analysis

1.1 Basic Checks

  • In the past year DFNS has reported negative net income.
  • DFNS had a negative operating cash flow in the past year.
  • DFNS had negative earnings in each of the past 5 years.
  • In the past 5 years DFNS always reported negative operating cash flow.
DFNS Yearly Net Income VS EBIT VS OCF VS FCFDFNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

  • DFNS's Return On Assets of -119.19% is on the low side compared to the rest of the industry. DFNS is outperformed by 93.50% of its industry peers.
Industry RankSector Rank
ROA -119.19%
ROE N/A
ROIC N/A
ROA(3y)-293.97%
ROA(5y)-177.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DFNS Yearly ROA, ROE, ROICDFNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DFNS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DFNS Yearly Profit, Operating, Gross MarginsDFNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 1 -1 -2 -3

1

2. DFNS Health Analysis

2.1 Basic Checks

  • DFNS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DFNS has less shares outstanding
  • The debt/assets ratio for DFNS has been reduced compared to a year ago.
DFNS Yearly Shares OutstandingDFNS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DFNS Yearly Total Debt VS Total AssetsDFNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -30.41, we must say that DFNS is in the distress zone and has some risk of bankruptcy.
  • DFNS has a Altman-Z score of -30.41. This is amonst the worse of the industry: DFNS underperforms 94.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.41
ROIC/WACCN/A
WACCN/A
DFNS Yearly LT Debt VS Equity VS FCFDFNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

2.3 Liquidity

  • DFNS has a Current Ratio of 0.12. This is a bad value and indicates that DFNS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.12, DFNS is not doing good in the industry: 96.39% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.12 indicates that DFNS may have some problems paying its short term obligations.
  • The Quick ratio of DFNS (0.12) is worse than 96.39% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
DFNS Yearly Current Assets VS Current LiabilitesDFNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

0

3. DFNS Growth Analysis

3.1 Past

  • DFNS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3199.80%.
EPS 1Y (TTM)-3199.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-192.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DFNS Yearly Revenue VS EstimatesDFNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 5M 10M 15M

0

4. DFNS Valuation Analysis

4.1 Price/Earnings Ratio

  • DFNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DFNS Price Earnings VS Forward Price EarningsDFNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DFNS Per share dataDFNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. DFNS Dividend Analysis

5.1 Amount

  • DFNS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DFNS Fundamentals: All Metrics, Ratios and Statistics

T3 DEFENSE INC

NASDAQ:DFNS (3/13/2026, 10:05:06 AM)

1.235

+0.03 (+2.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-02
Earnings (Next)05-01
Inst Owners5.71%
Inst Owner ChangeN/A
Ins Owners34.96%
Ins Owner ChangeN/A
Market Cap30.13M
Revenue(TTM)N/A
Net Income(TTM)-8.52M
Analysts0
Price TargetN/A
Short Float %24.78%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS-2.19
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -119.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-293.97%
ROA(5y)-177.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30916.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -30.41
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3199.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-192.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-458.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-414.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-321.05%
OCF growth 3YN/A
OCF growth 5YN/A

T3 DEFENSE INC / DFNS FAQ

What is the ChartMill fundamental rating of T3 DEFENSE INC (DFNS) stock?

ChartMill assigns a fundamental rating of 0 / 10 to DFNS.


What is the valuation status for DFNS stock?

ChartMill assigns a valuation rating of 0 / 10 to T3 DEFENSE INC (DFNS). This can be considered as Overvalued.


Can you provide the profitability details for T3 DEFENSE INC?

T3 DEFENSE INC (DFNS) has a profitability rating of 0 / 10.


Can you provide the financial health for DFNS stock?

The financial health rating of T3 DEFENSE INC (DFNS) is 1 / 10.